{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:08:13Z","timestamp":1783721293874,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204842"],"award-info":[{"award-number":["82204842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973795"],"award-info":[{"award-number":["81973795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"YangFan project from the Science and Technology Commission of Shanghai Municipality","award":["22YF1445400"],"award-info":[{"award-number":["22YF1445400"]}]},{"name":"Traditional Chinese Medicine Science and Technology Development Project of Shanghai Medical Innovation & Development Foundation","award":["WL-QNRC-2022003K"],"award-info":[{"award-number":["WL-QNRC-2022003K"]}]},{"name":"Traditional Chinese Medicine Science and Technology Development Project of Shanghai Medical Innovation & Development Foundation","award":["WL-LXBB-2021001K"],"award-info":[{"award-number":["WL-LXBB-2021001K"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-024-02753-3","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T14:26:51Z","timestamp":1731940011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel prediction model for the prognosis of non-small cell lung cancer with clinical routine laboratory indicators: a machine learning approach"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"issue":"1","key":"2753_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2753_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jtho.2020.11.026","volume":"16","author":"T Chu","year":"2021","unstructured":"Chu T, Zhong R, Zhong H, Zhang B, Zhang W, Shi C, Qian J, Zhang Y, Chang Q, Zhang X, et al. Phase 1b study of Sintilimab Plus Anlotinib as First-line therapy in patients with Advanced NSCLC. J Thorac Oncol. 2021;16(4):643\u201352.","journal-title":"J Thorac Oncol"},{"issue":"8","key":"2753_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.31128\/AJGP-11-19-5148","volume":"49","author":"R McLellan","year":"2020","unstructured":"McLellan R, Marshall H, Dent A, Bowman RV, Yang IA, Fong KM. Diagnosis and treatment of early lung cancer. Aust J Gen Pract. 2020;49(8):508\u201312.","journal-title":"Aust J Gen Pract"},{"issue":"3","key":"2753_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13353-023-00750-2","volume":"64","author":"M Frydrychowicz","year":"2023","unstructured":"Frydrychowicz M, Kuszel L, Dworacki G, Budna-Tukan J. MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy. J Appl Genet. 2023;64(3):459\u201377.","journal-title":"J Appl Genet"},{"issue":"19","key":"2753_CR5","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.1002\/cam4.3379","volume":"9","author":"J Wu","year":"2020","unstructured":"Wu J, Shen Z. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer. Cancer Med. 2020;9(19):6909\u201322.","journal-title":"Cancer Med"},{"issue":"1","key":"2753_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12916-023-02954-z","volume":"21","author":"K Chen","year":"2023","unstructured":"Chen K, Kang G, Zhang Z, Lizaso A, Beck S, Lyskjaer I, Chervova O, Li B, Shen H, Wang C, et al. Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer. BMC Med. 2023;21(1):255.","journal-title":"BMC Med"},{"issue":"1","key":"2753_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13402-019-00470-y","volume":"43","author":"M Yousefi","year":"2020","unstructured":"Yousefi M, Ghaffari P, Nosrati R, Dehghani S, Salmaninejad A, Abarghan YJ, Ghaffari SH. Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cell Oncol (Dordr). 2020;43(1):31\u201349.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"2753_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12890-020-1139-5","volume":"20","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Zhong H, Ye L, Li Q, Fang S, Gu W, Qian Y. Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis. BMC Pulm Med. 2020;20(1):96.","journal-title":"BMC Pulm Med"},{"key":"2753_CR9","doi-asserted-by":"publisher","first-page":"153303382098308","DOI":"10.1177\/1533033820983085","volume":"20","author":"J Jin","year":"2021","unstructured":"Jin J, Yang L, Liu D, Li WM. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in Lung Cancer: a systematic review and Meta-analysis. Technol Cancer Res Treat. 2021;20:1533033820983085.","journal-title":"Technol Cancer Res Treat"},{"issue":"14","key":"2753_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2217\/bmm-2019-0583","volume":"14","author":"S Sun","year":"2020","unstructured":"Sun S, Qu Y, Wen F, Yu H. Initial neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with inoperable locally advanced non-small-cell lung cancer. Biomark Med. 2020;14(14):1341\u201352.","journal-title":"Biomark Med"},{"key":"2753_CR11","doi-asserted-by":"publisher","first-page":"107327482110282","DOI":"10.1177\/10732748211028257","volume":"28","author":"T Liu","year":"2021","unstructured":"Liu T, Zhou T, Luo F, Yang Y, Zhao S, Huang Y, Zhao H, Zhang L, Zhao Y. Clinical significance of kinetics of Low-Density Lipoprotein Cholesterol and its Prognostic Value in Limited Stage Small Cell Lung Cancer patients. Cancer Control. 2021;28:10732748211028257.","journal-title":"Cancer Control"},{"issue":"1","key":"2753_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12885-017-3239-z","volume":"17","author":"T Zhou","year":"2017","unstructured":"Zhou T, Zhan J, Fang W, Zhao Y, Yang Y, Hou X, Zhang Z, He X, Zhang Y, Huang Y, et al. Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC). BMC Cancer. 2017;17(1):269.","journal-title":"BMC Cancer"},{"issue":"1","key":"2753_CR13","first-page":"100001","volume":"1","author":"EB Garon","year":"2020","unstructured":"Garon EB, Chih-Hsin Yang J, Dubinett SM. The role of Interleukin 1beta in the pathogenesis of Lung Cancer. JTO Clin Res Rep. 2020;1(1):100001.","journal-title":"JTO Clin Res Rep"},{"key":"2753_CR14","doi-asserted-by":"crossref","unstructured":"Leung JH, Ng B, Lim WW. Interleukin-11: a potential biomarker and molecular therapeutic target in Non-small Cell Lung Cancer. Cells 2022, 11(14).","DOI":"10.3390\/cells11142257"},{"issue":"9","key":"2753_CR15","doi-asserted-by":"publisher","first-page":"e0185168","DOI":"10.1371\/journal.pone.0185168","volume":"12","author":"XF Wang","year":"2017","unstructured":"Wang XF, Zhu YT, Wang JJ, Zeng DX, Mu CY, Chen YB, Lei W, Zhu YH, Huang JA. The prognostic value of interleukin-17 in lung cancer: a systematic review with meta-analysis based on Chinese patients. PLoS ONE. 2017;12(9):e0185168.","journal-title":"PLoS ONE"},{"issue":"1","key":"2753_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12885-022-09628-8","volume":"22","author":"G Eberst","year":"2022","unstructured":"Eberst G, Vernerey D, Laheurte C, Meurisse A, Kaulek V, Cuche L, Jacoulet P, Almotlak H, Lahourcade J, Gainet-Brun M, et al. Prognostic value of CD4\u2009+\u2009T lymphopenia in non-small cell lung Cancer. BMC Cancer. 2022;22(1):529.","journal-title":"BMC Cancer"},{"issue":"24","key":"2753_CR17","doi-asserted-by":"publisher","first-page":"36065","DOI":"10.18632\/oncotarget.9130","volume":"7","author":"S Zhao","year":"2016","unstructured":"Zhao S, Jiang T, Zhang L, Yang H, Liu X, Jia Y, Zhou C. Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: a systematic review with meta-analysis. Oncotarget. 2016;7(24):36065\u201373.","journal-title":"Oncotarget"},{"issue":"12","key":"2753_CR18","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1118\/1.3005641","volume":"35","author":"Y Yuan","year":"2008","unstructured":"Yuan Y, Giger ML, Li H, Sennett C. Correlative feature analysis on FFDM. Med Phys. 2008;35(12):5490\u2013500.","journal-title":"Med Phys"},{"issue":"22","key":"2753_CR19","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1002\/cam4.4782","volume":"11","author":"L Yang","year":"2022","unstructured":"Yang L, Fan X, Qin W, Xu Y, Zou B, Fan B, Wang S, Dong T, Wang L. A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer. Cancer Med. 2022;11(22):4246\u201355.","journal-title":"Cancer Med"},{"issue":"7","key":"2753_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.trecan.2024.04.004","volume":"10","author":"C Abbosh","year":"2024","unstructured":"Abbosh C, Hodgson D, Doherty GJ, Gale D, Black JRM, Horn L, Reis-Filho JS, Swanton C. Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer. Trends Cancer. 2024;10(7):643\u201354.","journal-title":"Trends Cancer"},{"issue":"9","key":"2753_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00520-023-07997-9","volume":"31","author":"XY Liu","year":"2023","unstructured":"Liu XY, Zhang X, Zhang Q, Ruan GT, Liu T, Xie HL, Ge YZ, Song MM, Deng L, Shi HP. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer. Support Care Cancer. 2023;31(9):533.","journal-title":"Support Care Cancer"},{"issue":"8","key":"2753_CR22","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.21037\/jtd-2019-itm-013","volume":"12","author":"Y Gao","year":"2020","unstructured":"Gao Y, Zhou R, Lyu Q. Multiomics and machine learning in lung cancer prognosis. J Thorac Dis. 2020;12(8):4531\u20135.","journal-title":"J Thorac Dis"},{"key":"2753_CR23","doi-asserted-by":"crossref","unstructured":"Benzekry S, Grangeon M, Karlsen M, Alexa M, Bicalho-Frazeto I, Chaleat S, Tomasini P, Barbolosi D, Barlesi F, Greillier L. Machine Learning for Prediction of Immunotherapy Efficacy in Non-Small Cell Lung Cancer from Simple Clinical and Biological Data. Cancers (Basel) 2021, 13(24).","DOI":"10.3390\/cancers13246210"},{"issue":"12","key":"2753_CR24","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1002\/cam4.4617","volume":"11","author":"W Liu","year":"2022","unstructured":"Liu W, Wang S, Ye Z, Xu P, Xia X, Guo M. Prediction of lung metastases in thyroid cancer using machine learning based on SEER database. Cancer Med. 2022;11(12):2503\u201315.","journal-title":"Cancer Med"},{"issue":"1","key":"2753_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0169-5002(96)00572-7","volume":"15","author":"T Yano","year":"1996","unstructured":"Yano T, Yoshino I, Yokoyama H, Fukuyama Y, Takai E, Asoh H, Ichinose Y. The clinical significance of serum soluble interleukin-2 receptors in lung cancer. Lung Cancer. 1996;15(1):79\u201384.","journal-title":"Lung Cancer"},{"issue":"3","key":"2753_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF02523660","volume":"7","author":"O Kawashima","year":"2000","unstructured":"Kawashima O, Kamiyoshihara M, Sakata S, Endo K, Saito R, Morishita Y. The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients. Ann Surg Oncol. 2000;7(3):239\u201345.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2753_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-5002(98)00094-4","volume":"23","author":"G Brunetti","year":"1999","unstructured":"Brunetti G, Bossi A, Baiardi P, Jedrychowska I, Pozzi U, Bacchella L, Bernardo G. Soluble interleukin 2 receptor (sIL2R) in monitoring advanced lung cancer during chemotherapy. Lung Cancer. 1999;23(1):1\u20139.","journal-title":"Lung Cancer"},{"issue":"3","key":"2753_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10637-023-01358-3","volume":"41","author":"T Tozuka","year":"2023","unstructured":"Tozuka T, Yanagitani N, Yoshida H, Manabe R, Ogusu S, Tsugitomi R, Sakamoto H, Amino Y, Ariyasu R, Uchibori K, et al. Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1\/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients. Invest New Drugs. 2023;41(3):411\u201320.","journal-title":"Invest New Drugs"},{"issue":"3","key":"2753_CR29","doi-asserted-by":"publisher","first-page":"e12776","DOI":"10.1111\/cpr.12776","volume":"53","author":"W Liu","year":"2020","unstructured":"Liu W, Wang H, Bai F, Ding L, Huang Y, Lu C, Chen S, Li C, Yue X, Liang X, et al. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-kappaB. Cell Prolif. 2020;53(3):e12776.","journal-title":"Cell Prolif"},{"issue":"29","key":"2753_CR30","doi-asserted-by":"publisher","first-page":"27651","DOI":"10.18632\/oncotarget.4753","volume":"6","author":"S Duan","year":"2015","unstructured":"Duan S, Tsai Y, Keng P, Chen Y, Lee SO, Chen Y. IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules. Oncotarget. 2015;6(29):27651\u201360.","journal-title":"Oncotarget"},{"issue":"8","key":"2753_CR31","doi-asserted-by":"publisher","first-page":"e43075","DOI":"10.1371\/journal.pone.0043075","volume":"7","author":"B Zhou","year":"2012","unstructured":"Zhou B, Liu J, Wang ZM, Xi T. C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis. PLoS ONE. 2012;7(8):e43075.","journal-title":"PLoS ONE"},{"issue":"1","key":"2753_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.21037\/apm-20-2229","volume":"10","author":"J An","year":"2021","unstructured":"An J, Gu Q, Cao L, Yang H, Deng P, Hu C, Li M. Serum IL-6 as a vital predictor of severe lung cancer. Ann Palliat Med. 2021;10(1):202\u20139.","journal-title":"Ann Palliat Med"},{"issue":"1","key":"2753_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12916-022-02356-7","volume":"20","author":"C Liu","year":"2022","unstructured":"Liu C, Yang L, Xu H, Zheng S, Wang Z, Wang S, Yang Y, Zhang S, Feng X, Sun N, et al. Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer. BMC Med. 2022;20(1):187.","journal-title":"BMC Med"},{"key":"2753_CR34","doi-asserted-by":"crossref","unstructured":"Naqash AR, McCallen JD, Mi E, Iivanainen S, Marie MA, Gramenitskaya D, Clark J, Koivunen JP, Macherla S, Jonnalagadda S et al. Increased interleukin-6\/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer 2023, 11(10).","DOI":"10.1136\/jitc-2023-007310"},{"issue":"5","key":"2753_CR35","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1007\/s13277-014-3006-6","volume":"36","author":"M Gomes","year":"2015","unstructured":"Gomes M, Coelho A, Araujo A, Azevedo A, Teixeira AL, Catarino R, Medeiros R. IL-6 polymorphism in non-small cell lung cancer: a prognostic value? Tumour Biol. 2015;36(5):3679\u201384.","journal-title":"Tumour Biol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-024-02753-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T15:03:45Z","timestamp":1731942225000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-024-02753-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2753"],"URL":"https:\/\/doi.org\/10.1186\/s12911-024-02753-3","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"20 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Shanghai Municipal Hospital of Traditional Chinese Medicine approved the human studies. The studies were conducted under local legislation and institutional requirements. The participants provided written informed consent to participate in this study (approval number: 2023SHL-KY-20-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics in publishing"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors had final approval of the version to be published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author agreement"}}],"article-number":"344"}}